Alzinova completes humanisation work and selects lead candidate for monoclonal antibody ALZ-201
/PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company, today announces the company has successfully completed the humanisation work and...